SCHEMBL29411419

SCHEMBL29411419

Cc1ccc(C(=O)NCCC(O)c2ccc(-c3ccccc3F)cc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HIF1A Q16665 1/20 0.43
KMT2A Q03164 1/20 0.43
RIPK1 Q13546 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP19A1 P11511 1/20 0.40
GRM5 P41594 1/20 0.40
CYP2J2 P51589 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045182 1.00 EPHX2 (0.48) EPHX2KDM4EALDH1A1MAPTL3MBTL1
SCHEMBL21045353 0.81 KMT2A (0.53) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL29411410 0.81 KDM4E (0.55) EPHX2KDM4EALDH1A1MAPTL3MBTL1
SCHEMBL29411582 0.81 KMT2A (0.53) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL21045178 0.81 KDM4E (0.55) EPHX2KDM4EALDH1A1MAPTL3MBTL1
SCHEMBL21045589 0.80 KDM4E (0.47) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL29411415 0.80 KDM4E (0.47) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL21045312 0.76 GABRA5 (0.47) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL29411418 0.76 GABRA5 (0.47) KDM4EALDH1A1MAPTL3MBTL1HIF1A
SCHEMBL21045335 0.76 LMNA (0.56) ALDH1A1MAPTL3MBTL1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB EPHX2 4380/4885KDM4E 4032/4885ALDH1A1 3048/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB EPHX2 4380/4885KDM4E 4032/4885ALDH1A1 3048/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB EPHX2 4380/4885KDM4E 4032/4885ALDH1A1 3048/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.